Cargando…

Use of Mac‐2 binding protein as a biomarker for nonalcoholic fatty liver disease diagnosis

In contrast to patients with viral hepatitis, patients with nonalcoholic fatty liver disease (NAFLD) can progress to hepatocellular carcinoma during the initial stages of liver fibrosis. Development and implementation of noninvasive methods for diagnosis and progression prediction are important for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamada, Yoshihiro, Ono, Masafumi, Hyogo, Hideyuki, Fujii, Hideki, Sumida, Yoshio, Yamada, Makoto, Mori, Kojiroh, Tanaka, Saiyu, Maekawa, Tomohiro, Ebisutani, Yusuke, Yamamoto, Akiko, Takamatsu, Shinji, Yoneda, Masashi, Kawada, Norifumi, Chayama, Kazuaki, Saibara, Toshiji, Takehara, Tetsuo, Miyoshi, Eiji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678915/ https://www.ncbi.nlm.nih.gov/pubmed/29404494 http://dx.doi.org/10.1002/hep4.1080

Ejemplares similares

Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population
por: Sumida, Yoshio, et al.
Publicado: (2012)

A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLD
por: Kawaguchi, Takumi, et al.
Publicado: (2018)

Glycemic Variability Is an Independent Predictive Factor for Development of Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease
por: Hashiba, Motoi, et al.
Publicado: (2013)

Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
por: Tokushige, Katsutoshi, et al.
Publicado: (2021)

Serum Mac‐2 binding protein level predicts the development of liver‐related events and colorectal cancer in patients with NAFLD
por: Kamada, Yoshihiro, et al.
Publicado: (2022)

Infection phase is a predictor of pruritus in patients with hepatitis B virus infection
por: Oeda, Satoshi, et al.
Publicado: (2019)

Evaluation of postprandial hypoglycemia in patients with nonalcoholic fatty liver disease by oral glucose tolerance testing and continuous glucose monitoring
por: Oki, Yusuke, et al.
Publicado: (2018)

Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis
por: Sumida, Yoshio, et al.
Publicado: (2020)

Serum Mac-2 Binding Protein Levels Associate with Metabolic Parameters and Predict Liver Fibrosis Progression in Subjects with Fatty Liver Disease: A 7-Year Longitudinal Study
por: Kamada, Yoshihiro, et al.
Publicado: (2020)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Decrease in fasting insulin secretory function correlates with significant liver fibrosis in Japanese non‐alcoholic fatty liver disease patients
por: Araki, Norimasa, et al.
Publicado: (2020)

Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease
por: Hotta, Kikuko, et al.
Publicado: (2010)

The FIB-4 Index Predicts the Development of Liver-Related Events, Extrahepatic Cancers, and Coronary Vascular Disease in Patients with NAFLD
por: Kamada, Yoshihiro, et al.
Publicado: (2022)

Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis
por: Kamada, Yoshihiro, et al.
Publicado: (2013)

Lack of 17β-estradiol reduces sensitivity to insulin in the liver and muscle of male mice
por: Toda, Katsumi, et al.
Publicado: (2018)

Type IV Collagen 7S Is the Most Accurate Test For Identifying Advanced Fibrosis in NAFLD With Type 2 Diabetes
por: Ishiba, Hiroshi, et al.
Publicado: (2020)

Bofutsushosan, a Japanese herbal (Kampo) medicine, attenuates progression of nonalcoholic steatohepatitis in mice
por: Ono, Masafumi, et al.
Publicado: (2013)

Evaluation of Fucosylated Haptoglobin and Mac-2 Binding Protein as Serum Biomarkers to Estimate Liver Fibrosis in Patients with Chronic Hepatitis C
por: Tawara, Seiichi, et al.
Publicado: (2016)

The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease
por: Fujii, Hideki, et al.
Publicado: (2020)

BART Inhibits Pancreatic Cancer Cell Invasion by PKCα Inactivation through Binding to ANX7
por: Taniuchi, Keisuke, et al.
Publicado: (2012)

KIF20A-Mediated RNA Granule Transport System Promotes the Invasiveness of Pancreatic Cancer Cells()
por: Taniuchi, Keisuke, et al.
Publicado: (2014)

Impact of plasma transaminase levels on the peripheral blood glutamate levels and memory functions in healthy subjects()
por: Kamada, Yoshihiro, et al.
Publicado: (2016)

Palmitate-induced lipotoxicity is crucial for the pathogenesis of nonalcoholic fatty liver disease in cooperation with gut-derived endotoxin
por: Ogawa, Yuji, et al.
Publicado: (2018)

Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study
por: Honda, Yasushi, et al.
Publicado: (2017)

Association of Serum Albumin Levels and Long-Term Prognosis in Patients with Biopsy-Confirmed Nonalcoholic Fatty Liver Disease
por: Takahashi, Hirokazu, et al.
Publicado: (2023)

Measurement of serum PODXL concentration for detection of pancreatic cancer
por: Taniuchi, Keisuke, et al.
Publicado: (2018)

WAVE2 is associated with poor prognosis in pancreatic cancers and promotes cell motility and invasiveness via binding to ACTN4
por: Taniuchi, Keisuke, et al.
Publicado: (2018)

Eradication of hepatitis C virus with direct‐acting antivirals improves glycemic control in diabetes: A multicenter study
por: Takahashi, Hirokazu, et al.
Publicado: (2020)

Analysis of factors influencing glucose tolerance in Japanese patients with non-alcoholic fatty liver disease
por: Ohmi, Satoko, et al.
Publicado: (2017)

Effect of urine pH changed by dietary intervention on uric acid clearance mechanism of pH-dependent excretion of urinary uric acid
por: Kanbara, Aya, et al.
Publicado: (2012)

FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic
por: Sumida, Yoshio, et al.
Publicado: (2021)

IGF2BP3-mediated translation in cell protrusions promotes cell invasiveness and metastasis of pancreatic cancer
por: Taniuchi, Keisuke, et al.
Publicado: (2014)

Efficient delivery of small interfering RNAs targeting particular mRNAs into pancreatic cancer cells inhibits invasiveness and metastasis of pancreatic tumors
por: Taniuchi, Keisuke, et al.
Publicado: (2019)

Overexpression of PODXL/ITGB1 and BCL7B/ITGB1 accurately predicts unfavorable prognosis compared to the TNM staging system in postoperative pancreatic cancer patients
por: Taniuchi, Keisuke, et al.
Publicado: (2019)

Differences in characteristics of glucose intolerance between patients with NAFLD and chronic hepatitis C as determined by CGMS
por: Ochi, Tsunehiro, et al.
Publicado: (2017)

Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods
por: Yoneda, Masato, et al.
Publicado: (2017)

Bach1 gene ablation reduces steatohepatitis in mouse MCD diet model
por: Inoue, Motoki, et al.
Publicado: (2011)

Tumor Necrosis Factor-α Promotes Cholestasis-Induced Liver Fibrosis in the Mouse through Tissue Inhibitor of Metalloproteinase-1 Production in Hepatic Stellate Cells
por: Osawa, Yosuke, et al.
Publicado: (2013)

Podocalyxin‐like protein, linked to poor prognosis of pancreatic cancers, promotes cell invasion by binding to gelsolin
por: Taniuchi, Keisuke, et al.
Publicado: (2016)

Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
por: Sumida, Yoshio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6qos42j45n6pvrghn8b5iq72go